LONDON, UK—-4th March 2010—-New Publications. Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for Staphylococcus aureus vaccines MarketVIEW: Staphylococcus aureus vaccines models the global market for this potentially lucrative new vaccine category now being prioritized by most major vaccine manufacturers. The product gives a comprehensive vaccine value ($USD/volume (000s) forecast for all R&D candidates within all potential risk population indications that would benefit from a preventative strategy. The model includes LO/BASE/HI forecast scenarios so the user can visualize the commercial impact of differing targetting/competitive and pricing scenarios to 2030. VISIT SITE TO LEARN MORE.
